Impact of patient age on the outcome of primary breast carcinoma.

about

Predictive value of pathological and immunohistochemical parameters for axillary lymph node metastasis in breast carcinoma.Clinical Significance of Age at the Time of Diagnosis among Young Breast Cancer Patients.

P2860

Q34748822-40B4002B-A4D6-47E7-81C7-0CD8B1E08D7B Q35713872-59D482A5-BBE4-4632-A956-20F41AF822CC

P2860

Impact of patient age on the outcome of primary breast carcinoma.

Item

http://www.wikidata.org/entity/Q53671085

description

2002 nî lūn-bûn

@nan

2002年の論文

@ja

2002年学术文章

@wuu

2002年学术文章

@zh

2002年学术文章

@zh-cn

2002年学术文章

@zh-hans

2002年学术文章

@zh-my

2002年学术文章

@zh-sg

2002年學術文章

@yue

2002年學術文章

@zh-hant

name

Impact of patient age on the outcome of primary breast carcinoma.

@en

Impact of patient age on the outcome of primary breast carcinoma.

@nl

type

Item

label

Impact of patient age on the outcome of primary breast carcinoma.

@en

Impact of patient age on the outcome of primary breast carcinoma.

@nl

prefLabel

Impact of patient age on the outcome of primary breast carcinoma.

@en

Impact of patient age on the outcome of primary breast carcinoma.

@nl

P1476

Impact of patient age on the outcome of primary breast carcinoma.

@en

P2093

Eun Kyong Kim

http://www.w3.org/2001/XMLSchema#string

Kyong Sik Lee

http://www.w3.org/2001/XMLSchema#string

Seung-Il Kim

http://www.w3.org/2001/XMLSchema#string

Woo-Ick Yang

http://www.w3.org/2001/XMLSchema#string

P2860

Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

Proportional hazards and recursive partitioning and amalgamation analyses of the Southwest Oncology Group node-positive adjuvant CMFVP breast cancer data base: a pilot study.

The contribution of molecular markers to the prediction of response in the treatment of breast cancer: a review of the literature on HER-2, p53 and BCL-2.

Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer. Seventh International Conference on Adjuvant Therapy of Primary Breast Cancer.

Prognostic value of urokinase-type plasminogen activator (uPA) and plasminogen activator inhibitors PAI-1 and PAI-2 in breast carcinomas

Early-onset breast cancer--histopathological and prognostic considerations

Genetic evolution of breast cancers. III: Age-dependent variations in the correlations between biological indicators of prognosis.

The lack of age as a significant prognostic factor in non-metastatic breast cancer.

Role of age as a prognostic factor in breast cancer.

P304

12-18

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/JSO.10088

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Byeong-Woo Park

P577

2002-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

11967900

http://www.w3.org/2001/XMLSchema#string

Impact of patient age on the outcome of primary breast carcinoma.

about

P2860

P2860

Impact of patient age on the outcome of primary breast carcinoma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698